Lemaitre Vascular (NASDAQ:LMAT) reported Q4 EPS of $0.25, $0.01 worse than the analyst estimate of $0.26. Revenue for the quarter came in at $41 million versus the consensus estimate of $41 million.
GUIDANCE:
Lemaitre Vascular sees Q1 2023 EPS of $0.22-$0.27, versus the consensus of $0.27. Lemaitre Vascular sees Q1 2023 revenue of $42.6-45 million, versus the consensus of $41.6 million.
Lemaitre Vascular sees FY2023 EPS of $1.11-$1.20, versus the consensus of $1.19. Lemaitre Vascular sees FY2023 revenue of $174.3-178.3 million, versus the consensus of $171.4 million.